Who owns CGWhat CG owns
What Carlyle Group Inc. owns
The company's own 13F portfolio · as of 2026-09-30 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F
$8.36B
disclosed stock portfolio
16
positions
77.6%
in MDLN
Positions, as of 2026-09-30
ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | MDLNMedline Inc | 187.1M | $6.49B | 77.6% |
| 2 | SAROStandardaero Inc | 84.6M | $1.81B | 21.6% |
| 3 | PHATPhathom Pharmaceuticals Inc | 3.5M | $25.5M | 0.3% |
| 4 | PONYPony Ai Inc | 2.4M | $15.5M | 0.2% |
| 5 | INVHInvitation Homes Inc | 477,500 | $12.6M | 0.2% |
| 6 | SPRBSpruce Biosciences Inc | 38,620 | $1.9M | 0% |
| 7 | FWRDForward Air Corp | 107,214 | $1.6M | 0% |
| 8 | ACETAdicet Bio Inc | 184,295 | $1.3M | 0% |
| 9 | HOODRobinhood Mkts Inc | 8,767 | $986,288 | 0% |
| 10 | DNUTKrispy Kreme Inc | 340,748 | $977,947 | 0% |
| 11 | OKUROnkure Therapeutics Inc | 269,895 | $735,464 | 0% |
| 12 | SPWRSunPower Inc | 2.3M | $719,766 | 0% |
| 13 | JSPRJasper Therapeutics Inc | 1.1M | $618,390 | 0% |
| 14 | METCRamaco Res Inc | 52,922 | $437,669 | 0% |
| 15 | NBISNebius Group N.V. | 1,846 | $435,434 | 0% |
| 16 | NABLN-able Inc | 93,732 | $384,301 | 0% |
Source: SEC Form 13F-HR filed by Carlyle Group Inc. (CIK 1527166), reporting period 2026-09-30. Values are quarter-end filed marks. Research, not investment advice.